[EMAIL PROTECTED] writes:
Hi Sue,
No hype, huh?
>Sue Hartigan <[EMAIL PROTECTED]> writes:
>New drug combination eliminates cancer in mice
>...hailed as "the single most exciting thing on the horizon" of cancer
>treatment by Dr. Richard Klausner, National Cancer Institute Director.
[Is this anybody's idea of a considered scientific evaluation of a possible
future cancer treatment? Can anybody spell hyperbole? I assure you many
others are sure they have the best thing available.]
>Because clinical trials of angiostatin and endostatin are not yet
>underway, patients may consider clinical trials of other
>anti-angiogenesis drugs such as TNP-470, carboxyamidotriazole, anti-VEGF,
or >thalidomide,
[Some may remember that last drug. In its previous incarnation it was, of
course, an anti-nausea drug that had some rather notable side effects that
weren't discovered quickly.]
>The American Cancer Society spends over 91 million dollars on cancer
>research each year, including several angiogenesis research projects.
[Several, huh? New idea?]
I deleted all the usual cautions that not everyone reads but are
indisputably included in news stories. Warnings on a pack of cigarettes
would have stopped smoking if people always paid attention to the fine print.
Best, Terry
"Lawyer - one trained to circumvent the law" - The Devil's Dictionary
Subscribe/Unsubscribe, email: [EMAIL PROTECTED]
In the body of the message enter: subscribe/unsubscribe law-issues
